Objective 1
Evaluate physician attitude & confidence regarding data presented at the conference
A Pharmaceutical company wanted to know what their key stakeholders thought and felt about new clinical data being presented at an important industry conference regarding their product
Evaluate physician attitude & confidence regarding data presented at the conference
Measure physician enthusiasm, or lack thereof, regarding the data that was presented
Determine impact data may have on HCPs' Rx behavior if product approved
The inVibe Solution
inVibe’s New Data Intelligence solution allowed our pharmaceutical client to quickly and efficiently deploy a voice-powered research study to gauge physician reactions to the data presented at a conference.
Within 3 days, inVibe recruited 20 cardiologists on client target list who had attended conference, in-person or virtually. The physicians reviewed data abstracts on their computers and smartphones, participated in an automated phone interview, and responded to questions about the data simply by speaking.

What were your reactions to the data, overall?
What specific questions or concerns do you have based on this?
What was the most compelling takeaway from the data sets being released?
Based on data/information shared at the conference, how do expect to treat your patients in the future?
inVibe's analysts leveraged their language expertise and advanced NLP tools to process, evaluate and analyze multiple aspects of each physician's response, including content, language, and emotion derived from speech-emotion recognition, allowing for deeper insights, faster.
The client received an interactive online dashboard with the voice data, transcripts, and a high-level analysis. An in-house analyst walked the team through each insight, anchoring recommendations in specific moments from the physician interviews.

Captured conference reactions from 20 cardiologists within three days to understand how new clinical data was landing.
The insights shaped the launch plan by spotlighting skeptical segments, showing where competitive context was needed, and prioritizing long-term safety narratives to boost confidence.
Insights & Next Steps
Based on the insights, inVibe recommended that the team take the following actions during a brand launch if the product received FDA approval:
Focus outreach on slow/late adopter physicians leveraging disease state educational campaigns to help overcome the low level of enthusiasm measured with this target segment
Present physicians with competitor data alongside their own data to create clear separation between treatment options, as language analysis showed stronger positive attitude among those familiar with competitor data
Develop case studies that highlight long-term safety data with low-risk patients, as this data generated the highest level of confidence with all physician segments